Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Latest posts
Last updated about 7 hours ago
Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency - Description of the Journal/Reference databases used
about 7 hours ago
Monitoring of medical literature and the entry of relevant information into the...
International Pharmaceutical Abstracts (IPA) journals
about 7 hours ago
International Pharmaceutical Abstracts (IPA) journals
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 6, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation: 23/05/2018, Revision: 19, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation...
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 5, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Tavneos, avacopan, Date of authorisation: 11/01/2022, Revision: 9, Status: Revoked
about 9 hours ago
Human medicines European public assessment report (EPAR): Tavneos, avacopan, Date of authorisation...
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 33, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation...
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 76, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation...
Product Management Service (PMS) public API - Frequently asked questions (FAQs)
about 11 hours ago
Product Management Service (PMS) public API - Frequently asked questions (FAQs)
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Date of authorisation: 30/06/2025, Revision: 4, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor /...
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 26, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation...